Adaptive Global Innovative Learning Environment for Glioblastoma: GBM AGILE
Adaptive Global Innovative Learning Environment for Glioblastoma: GBM AGILE
Abstract Glioblastoma (GBM) is a deadly disease with few effective therapies. Although much has been learned about the molecular characteristics of the disease, this knowledge has not been translated into clinical improvements for patients. At the same time, many new therapies are being developed. Many of these therapies have potential …